Trial intelligence / Profile preview

Epinephrine vs Albuterol in RSV Bronchiolitis

NCT00361452Phase 4Terminated

Sponsor
Rambam Health Care Campus
Start
Dec 2000
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of epinephrine in respiratory syncytial virus bronchiolitis (2 arms), sponsored by Rambam Health Care Campus. Primary endpoints: Respiratory Clinical Score at 30 months and Computerized Quantification of Wheezing and Crackles at 30 months. Started Dec 2000; status: terminated.

02

Drugs

epinephrine
03

Conditions

respiratory syncytial virus bronchiolitis

Beyond the preview

Go deeper on NCT00361452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00361452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call